Skip to main navigation Skip to search Skip to main content

Dietary intake of advanced glycation endproducts and risk of hepatobiliary cancers: A multinational cohort study

  • Ana Lucia Mayén
  • , Elom K. Aglago
  • , Viktoria Knaze
  • , Reynalda Cordova
  • , Casper G. Schalkwijk
  • , Karl Heinz Wagner
  • , Krasimira Aleksandrova
  • , Veronika Fedirko
  • , Pekka Keski-Rahkonen
  • , Michael F. Leitzmann
  • , Verena Katzke
  • , Bernard Srour
  • , Matthias B. Schulze
  • , Giovanna Masala
  • , Vittorio Krogh
  • , Salvatore Panico
  • , Rosario Tumino
  • , Bas Bueno-de-Mesquita
  • , Magritt Brustad
  • , Antonio Agudo
  • María Dolores Chirlaque López, Pilar Amiano, Bodil Ohlsson, Stina Ramne, Dagfinn Aune, Elisabete Weiderpass, Mazda Jenab, Heinz Freisling

Research output: Contribution to journal › Article › peer-review

Abstract

Advanced glycation endproducts (AGEs) may contribute to liver carcinogenesis because of their proinflammatory and prooxidative properties. Diet is a major source of AGEs, but there is sparse human evidence on the role of AGEs intake in liver cancer etiology. We examined the association between dietary AGEs and the risk of hepatobiliary cancers in the European Prospective Investigation into Cancer and Nutrition prospective cohort (n = 450 111). Dietary intake of three AGEs, Nε-[carboxymethyl]lysine (CML), Nε-[1-carboxyethyl]lysine (CEL) and Nδ-[5-hydro-5-methyl-4-imidazolon-2-yl]-ornithine (MG-H1), was estimated using country-specific dietary questionnaires linked to an AGEs database. Cause-specific hazard ratios (HR) and their 95% confidence intervals (CI) for associations between dietary AGEs and risk of hepatocellular carcinoma (HCC), gallbladder and biliary tract cancers were estimated using multivariable Cox proportional hazard regression. After a median follow-up time of 14.9 years, 255 cases of HCC, 100 cases of gallbladder cancer and 173 biliary tract cancers were ascertained. Higher intakes of dietary AGEs were inversely associated with the risk of HCC (per 1 SD increment, HR-CML = 0.87, 95% CI: 0.76-0.99, HR-CEL = 0.84, 95% CI: 0.74-0.96 and HR-MH-G1 = 0.84, 95% CI: 0.74-0.97). In contrast, positive associations were observed with risk of gallbladder cancer (per 1 SD, HR-CML = 1.28, 95% CI: 1.05-1.56, HR-CEL = 1.17; 95% CI: 0.96-1.40, HR-MH-G1 = 1.27, 95% CI: 1.06-1.54). No associations were observed for cancers of the intra and extrahepatic bile ducts. Our findings suggest that higher intakes of dietary AGEs are inversely associated with the risk of HCC and positively associated with the risk of gallbladder cancer.

Original languageEnglish (US)
Pages (from-to)854-864
Number of pages11
JournalInternational journal of cancer
Volume149
Issue number4
DOIs
StatePublished - Aug 15 2021
Externally publishedYes

Keywords

  • EPIC study
  • advanced glycation endproducts
  • bile duct cancers
  • gallbladder cancer
  • hepatocellular carcinoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Dietary intake of advanced glycation endproducts and risk of hepatobiliary cancers: A multinational cohort study'. Together they form a unique fingerprint.

Cite this